Catabasis Pharma (CATB) Stock News

Catabasis Renames As Astria Therapeutics With New Disease Focus

Once-struggling, Catabasis Pharmaceuticals Inc (NASDAQ: CATB) is looking to hit the reset button with a new name and focus. Catabasis has been dragging for several...

Catabasis Pharmaceuticals Announces New Company Name, Astria Therapeutics, Highlighting New Company Focus

Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2021

  Upgrades For Okta Inc (NASDAQ:

Mentions: BLDE ALKS VLTA SBUX ...

Catabasis Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides a Corporate Update

Catabasis Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference

Catabasis Pharmaceuticals To Present At Ladenburg Thalmann 2021 Healthcare Conference

2 Biotech Stocks Wall Street Predicts Will Rally By More Than 150%

The Biotech industry has been instrumental in developing treatments for the coronavirus. The sector’s long-term potential remains solid due to the aging populating and the rising cost of healthcare. Wall Street analysts expect biotech stocks Sorrento Therapeutics (SRNE) and Catabasis Pharmaceuticals (CATB) to deliver exponential returns in the upcoming months.

Mentions: SRNE

Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences

Catabasis Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides a Corporate Update

Catabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update

Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences